Market Analysiss

In the pharmaceutical domain, the UK dermatological drugs market is also on an upward trajectory. Valued at USD 882.5 million in 2024, it is expected to reach USD 1.64 billion by 2030, with a CAGR of 10.9% from 2025 to 2030. Psoriasis treatments constitute the largest and most rapidly expanding therapy area, driven by the introduction of novel biologics and increased patient awareness. ​

Digital health innovations, particularly teledermatology, are transforming patient care delivery in the UK. With approximately 24% of the population in England and Wales seeking medical advice for skin conditions, the adoption of digital platforms facilitates timely consultations and alleviates the burden on traditional healthcare services. The Department of Health supports the integration of digital technologies to enhance service quality and efficiency